Aureka Biotechnologies News

Latest Aureka Biotechnologies news, funding rounds and robotics & AI coverage. $100M raised. 1 article tracked by The Robotics Media.

About Aureka Biotechnologies

Aureka Biotechnologies is a US-China AI-native TechBio company developing biological foundation models and closed-loop experimental infrastructure that redesigns drug discovery end to end, combining large-scale pre-training, AI agents and high-throughput biology.

Key facts

Headquarters: Shanghai / Boston
Country: China
Founded: 2023
Sectors: AI Foundation Models, Digital Health
Website: https://aureka.bio

Funding rounds

Series B — $100M — 2026 — led by Granite Asia

Latest Aureka Biotechnologies news

Aureka Bags $100M Series B To Build Biology Foundation Model — AI-native TechBio startup Aureka Biotechnologies has closed a $100M Series B led by Granite Asia to train its biological foundation model and scale it...